COVID-19 antibodies persist, reduce reinfection risk for up to six months, study finds: The antibodies’ ability to neutralize COVID-19 did not differ significantly over the six-month period.
A Michigan Medicine study found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months. Researchers analyzed nearly 130 subjects with PCR-confirmed COVID-19 illness between three and six months after initial infection. Three patients were hospitalized while the rest were treated as outpatients and […]
Novel autoantibody adds fuel to COVID-19 ‘firestorm’ of inflammation, blood clots: The finding will likely help physicians develop targeted therapies for future COVID patients
Researchers at Michigan Medicine have discovered yet another functional autoantibody in COVID-19 patients that contributes to the disease’s development and the “firestorm” of blood clots and inflammation it induces. A growing body of studies suggests COVID-19 emulates many aspects of systemic autoimmune disorders, including the release of a flurry of overactive immune cells that produce […]